Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

September 30, 2016

Conditions
Hypoxic-ischemic EncephalopathyNeonatal EncephalopathyBirth Asphyxia
Interventions
DRUG

Erythropoietin

1000 U/kg/dose IV x 5 doses

DRUG

Normal saline

placebo: NS IV x 5 doses

Trial Locations (7)

20010

Children's National Medical Center, Washington D.C.

63110

Washington University, St Louis

72202

Arkansas Children's Hospital Research Institute, Little Rock

94143

UCSF, San Francisco

98105

Seattle Children's Hospital, Seattle

Unknown

Stanford University, Palo Alto

Kaiser Permanente, Santa Clara, Santa Clara

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

collaborator

Seattle Children's Hospital

OTHER

collaborator

Arkansas Children's Hospital Research Institute

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

Children's National Research Institute

OTHER

collaborator

Stanford University

OTHER

collaborator

Kaiser Permanente

OTHER

lead

University of California, San Francisco

OTHER